These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9863018)

  • 21. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The relationship between frameshift mutations of transforming growth factor-beta type II receptor, insulin growth factor II receptor, bcl-2 associated X protein, E2F4 and microsatellite instability in gastric carcinoma].
    Chen GT; Zhu ZG; Yin HR; Liu BY; Ji J; Zhang J; Lin YZ
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):344-8. PubMed ID: 16635398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions.
    Tani M; Takenoshita S; Kohno T; Hagiwara K; Nagamachi Y; Harris CC; Yokota J
    Carcinogenesis; 1997 May; 18(5):1119-21. PubMed ID: 9163705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
    Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation detection in the TGF-beta receptors and smad genes: RT-PCR and sequencing.
    Myeroff LL; He H; Fink SP; Markowitz S
    Methods Mol Biol; 2000; 142():139-47. PubMed ID: 10806620
    [No Abstract]   [Full Text] [Related]  

  • 27. No mutations of the Smad2 gene in human sporadic gastric carcinomas.
    Shitara Y; Yokozaki H; Yasui W; Takenoshita S; Kuwano H; Nagamachi Y; Tahara E
    Jpn J Clin Oncol; 1999 Jan; 29(1):3-7. PubMed ID: 10073143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of mutatins in the analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic humangastric cancer using genomic DNA and intron primers.
    Takenoshita S; Mogi A; Osawa H; Sunaga H; Kakegawa H; Tani M; Morinaga N; Kato R; Hagiwara K; Nagamachi Y
    Oncol Rep; 1998; 5(1):77-80. PubMed ID: 9458298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
    Xu J; Attisano L
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis.
    Ohtaki N; Yamaguchi A; Goi T; Fukaya T; Takeuchi K; Katayama K; Hirose K; Urano T
    Int J Oncol; 2001 Feb; 18(2):265-70. PubMed ID: 11172591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of p51 mutation in human hepatocellular carcinoma.
    Hamada K; Koyama T; Shimizu K; Ikawa S; Kawate S; Yokota J; Ohwada S; Morishita Y
    Cancer Lett; 2000 Feb; 148(2):161-4. PubMed ID: 10695992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel SMAD4 gene mutation in seminoma germ cell tumors.
    Bouras M; Tabone E; Bertholon J; Sommer P; Bouvier R; Droz JP; Benahmed M
    Cancer Res; 2000 Feb; 60(4):922-8. PubMed ID: 10706106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
    Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
    Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
    World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aberrations of Smad genes in human digestive tract cancers].
    Hagiwara K
    Tanpakushitsu Kakusan Koso; 2001 Feb; 46(2):124-9. PubMed ID: 11211786
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
    Tsang KJ; Tsang D; Brown TN; Crowe DL
    Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis.
    Miyaki M; Iijima T; Konishi M; Sakai K; Ishii A; Yasuno M; Hishima T; Koike M; Shitara N; Iwama T; Utsunomiya J; Kuroki T; Mori T
    Oncogene; 1999 May; 18(20):3098-103. PubMed ID: 10340381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of transforming growth factor beta receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity.
    Bae HJ; Eun JW; Noh JH; Kim JK; Jung KH; Xie HJ; Park WS; Lee JY; Nam SW
    Oncol Rep; 2009 Sep; 22(3):475-80. PubMed ID: 19639191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.